Dry Mouth Relief Market By Product Type (Spray, Mouthwash, Gel, Lozenges, Others) , By Type (Over-the-counter (OTC) , Prescribed) By Sales Channel (Online, Offline) : Global Opportunity Analysis and Industry Forecast, 2024-2033
The dry mouth relief market was valued at $2.5 billion in 2023, and is projected to reach $4.6 billion by 2033, growing at a CAGR of 6.1% from 2024 to 2033.
Dry mouth relief refers to interventions and products aimed at alleviating the symptoms of xerostomia, a condition where the salivary glands produce insufficient saliva. This can lead to discomfort, difficulty in speaking, eating, or swallowing, and an increased risk of dental problems such as cavities and gum disease. Dry mouth may result from various causes, including medication side effects, dehydration, medical treatments like radiation therapy, or underlying health conditions such as diabetes.
The growth of the global dry mouth relief market is driven by alarming increase in prevalence of chronic diseases and conditions such as Sjögren's syndrome and hypertension often lead to dry mouth, thus increasing the demand for effective relief products. According to a 2023 study published by Medscape—a leading online platform providing clinical news, health information, and educational resources for healthcare professionals worldwide—approximately 0.1-4% of the population is affected by Sjögren's syndrome. In addition, a 2023 study by the World Health Organization revealed that hypertension is prevalent among 1.28 billion adults aged 30–79 years worldwide. Furthermore, surge in geriatric population acts as the key driving force of the global market. This is attributed to the fact that older adults are more susceptible to dry mouth due to age-related changes and higher medication use. A 2024 study published by the World Health Organization revealed that the number of aged individuals will increase from 1 billion in 2020 to 1.4 billion by 2030. Moreover, the number of individuals aging 80 years and older is estimated to reach 426 million by 2050. In addition, increase in awareness about the importance of oral hygiene has heightened the demand for products like mouthwashes, lozenges, and saliva substitutes. Campaigns promoting oral health in schools and workplaces have further supported this trend. With growing interest in preventive healthcare, people are proactively seeking products to manage early symptoms of xerostomia, driving the market further. However, many individuals experiencing xerostomia do not recognize it as a medical condition requiring treatment. This limits the adoption of dry mouth relief products, especially in low-income and rural areas where access to healthcare information is limited. Furthermore, high cost associated with premium products like prescription-based saliva substitutes or advanced therapies restrains the growth of the market. On the contrary, innovations in product formulations, such as sugar-free lozenges, long-lasting sprays, and all-natural remedies, cater to diverse consumer preferences and expand market reach. For instance, products containing xylitol and aloe vera are gaining popularity for their moisturizing and protective benefits. Such developments are expected to offer lucrative opportunities for the expansion of the global market during the forecast period.
The global dry mouth relief market size is segmented into product type, type, sales channel, and region. On the basis of product type, the market is categorized into spray, mouthwash, gel, lozenges, and others. By type, it is classified into over-the-counter (OTC) and prescribed. Depending on sales channel, it is divided into online and offline. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key FindingsBy product type, the mouthwash segment is expected to dominate the market from 2024 to 2033.On the basis of type, the prescribed segment is anticipated to exhibit the highest growth during the forecast period.
Depending on sales channel, the offline segment is projected to emerge as the dominating segment in the coming years.
Region wise, in North America, the dry mouth relief market is likely to witness notable growth throughout the forecast period.
Competition AnalysisCompetitive analysis and profiles of the major players in the global dry mouth relief market include SUNSTAR Suisse S.A., Sanofi, bioXtra, A. S. Pharma, Colgate-Palmolive, 3M, Fresenius Kabi, Oralieve, Haleon, and Parnell Pharmaceuticals Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.
Key Market SegmentsBy Product TypeSpray
Mouthwash
Gel
Lozenges
Others
By TypeOver-the-counter (OTC)
Prescribed
By Sales ChannelOnline
Offline
Hospital Pharmacies
Retail Pharmacies
Others
By RegionNorth America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market PlayersSUNSTAR Suisse S.A.
Sanofi
bioXtra
A. S. Pharma
Colgate-Palmolive
3M
Fresenius Kabi
Oralieve
Haleon
Parnell Pharmaceuticals Inc.